Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 2
1974 1
1975 5
1976 1
1978 2
1979 1
1980 1
1982 2
1984 3
1985 3
1987 1
1992 2
1993 4
1994 1
1995 4
1997 3
1998 6
1999 11
2000 5
2001 7
2002 10
2003 8
2004 6
2005 7
2006 6
2007 2
2008 1
2009 2
2011 2
2012 4
2013 5
2014 3
2015 2
2016 3
2017 4
2018 8
2019 4
2020 3
2021 2
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Translational research on advanced therapies.
Belardelli F, Rizza P, Moretti F, Carella C, Galli MC, Migliaccio G. Belardelli F, et al. Among authors: carella c. Ann Ist Super Sanita. 2011;47(1):72-8. doi: 10.4415/ANN_11_01_15. Ann Ist Super Sanita. 2011. PMID: 21430343 Free article. Review.
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Nanda VGY, Peng W, Hwu P, Davies MA, Ciliberto G, Fattore L, Malpicci D, Aurisicchio L, Ascierto PA, Croce CM, Mancini R, Spranger S, Gajewski TF, Wang Y, Ferrone S, Vanpouille-Box C, Wennerberg E, Pilones KA, Formenti SC, Demaria S, Tang H, Wang Y, Fu YX, Dummer R, Puzanov I, Tarhini A, Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sanders C, Kirkwood JM, Chen THT, Maurer M, Korman AJ, Zarour HM, Stroncek DF, Huber V, Rivoltini L, Thurin M, Rau T, Lugli A, Pagès F, Camarero J, Sancho A, Jommi C, de Coaña YP, Wolodarski M, Yoshimoto Y, Gentilcore G, Poschke I, Masucci GV, Hansson J, Kiessling R, Scognamiglio G, Sabbatino F, Marino FZ, Anniciello AM, Cantile M, Cerrone M, Scala S, D’alterio C, Ianaro A, Cirin G, Liguori G, Bott G, Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D, Hamid O, Testori A, Lorigan P, Sosman JA, Flaherty KT, Yue H, Coleman S, Caro I, Hauschild A, McArthur GA, Sznol M, Callahan MK, Kluger H, Postow MA, Gordan R, Segal NH, Rizvi NA, Lesokhin A, Atkins MB, Burke MM, Ralabate A, Rivera A, Kronenberg SA, Agunwamba B, Ruisi M, Horak C, Jiang J, Wolchok J, Ascierto PA, Liszkay G, Maio M, Mandalà M, Demidov L, Stoyakovskiy D, Thomas L, de la Cruz-Me… See abstract for full author list ➔ Nanda VGY, et al. Among authors: carella c. J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2. J Transl Med. 2016. PMID: 27461275 Free PMC article.
Current guidelines for adult GH replacement.
Doga M, Bonadonna S, Gola M, Solerte SB, Amato G, Carella C, Giustina A. Doga M, et al. Among authors: carella c. Rev Endocr Metab Disord. 2005 Jan;6(1):63-70. doi: 10.1007/s11154-005-5226-y. Rev Endocr Metab Disord. 2005. PMID: 15711916 Review. No abstract available.
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.
Iacovelli R, Ciccarese C, Brunelli M, Battelli N, Buttigliero C, Caserta C, Buti S, Santini D, Carella C, Galli L, Verri E, Ermacora P, Merler S, Masini C, De Vivo R, Milesi L, Spina F, Rizzo M, Sperduti I, Fornarini G, Tortora G. Iacovelli R, et al. Among authors: carella c. Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2. Ann Oncol. 2022. PMID: 35926813 Free article. Clinical Trial.
Light, blindness and endocrine secretions.
Bellastella A, Amato G, Bizzaro A, Carella C, Criscuolo T, Iorio S, Muccitelli VI, Pisano G, Sinisi AA, De Bellis A. Bellastella A, et al. Among authors: carella c. J Endocrinol Invest. 1999 Dec;22(11):874-85. doi: 10.1007/BF03343663. J Endocrinol Invest. 1999. PMID: 10710278 Review. No abstract available.
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.
Tuninetti V, Ghisoni E, Pignata S, Picardo E, Raspagliesi F, Andreetta C, Maldi E, Artioli G, Mammoliti S, Zanchi L, Sikokis A, Biglia N, Parisi A, Mandato VD, Carella C, Cormio G, Marinaccio M, Puppo A, Paolini B, Borsotti L, Scotto G, Turinetto M, Sangiolo D, Di Maio M, Valabrega G. Tuninetti V, et al. Among authors: carella c. Cancers (Basel). 2023 Feb 6;15(4):1032. doi: 10.3390/cancers15041032. Cancers (Basel). 2023. PMID: 36831376 Free PMC article.
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Stellato M, Buti S, Maruzzo M, Bersanelli M, Pierantoni F, De Giorgi U, Di Napoli M, Iacovelli R, Vitale MG, Ermacora P, Malgeri A, Maiorano BA, Prati V, Mennitto A, Cavo A, Santoni M, Carella C, Fratino L, Procopio G, Verzoni E, Santini D. Stellato M, et al. Among authors: carella c. Int J Mol Sci. 2023 Jan 6;24(2):1096. doi: 10.3390/ijms24021096. Int J Mol Sci. 2023. PMID: 36674615 Free PMC article.
152 results